This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Guardant Health, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tracy Nance and a Patent for Distinguishing Somatic and Germline Variants.
Introduction
Tracy Nance is an inventor associated with Redwood City, California, and Guardant Health, Inc. Her patent work addresses a challenge in genetic analysis: determining whether a nucleic acid variant originated in a tumor or was inherited.
Latest Patents
Nance is named on 1 patent, titled “Methods and Systems for Differentiating Somatic and Germline Variants.” The disclosed method evaluates a variant using quantitative measures, including total and minor allele counts, and an associated variable. It then uses a statistical model to estimate expected germline mutant allele counts and calculates a probability value. Based on a predetermined threshold, the method classifies the variant as either somatic or germline.
Career Highlights
Nance’s listed company affiliation is Guardant Health, Inc. The patent reflects work on analytical methods for interpreting genetic variants, with potential relevance to distinguishing acquired changes from inherited ones.
Collaborations
The provided information identifies Elena Helman and Darya Chudova as Nance’s coworkers. It does not specify their roles in the patent or describe particular collaborative contributions.
Conclusion
Tracy Nance’s patent focuses on a statistical approach to classifying genetic variants by origin, connecting her listed work at Guardant Health with an important problem in genomic analysis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
